EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H16N2O3 |
| Net Charge | 0 |
| Average Mass | 296.326 |
| Monoisotopic Mass | 296.11609 |
| SMILES | CN1C(=O)c2ccccc2NC(=O)[C@@H]1Cc1ccc(O)cc1 |
| InChI | InChI=1S/C17H16N2O3/c1-19-15(10-11-6-8-12(20)9-7-11)16(21)18-14-5-3-2-4-13(14)17(19)22/h2-9,15,20H,10H2,1H3,(H,18,21)/t15-/m0/s1 |
| InChIKey | SNAVUESMLHTSHM-HNNXBMFYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Aspergillus (ncbitaxon:5052) | - | PubMed (25906695) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 14-hydroxy-cyclopeptine (CHEBI:206570) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (3S)-3-[(4-hydroxyphenyl)methyl]-4-methyl-1,3-dihydro-1,4-benzodiazepine-2,5-dione |
| Manual Xrefs | Databases |
|---|---|
| 58196413 | ChemSpider |